Annual EBITDA:
-$191.90M-$52.87M(-38.02%)Summary
- As of today, CLDX annual EBITDA is -$191.90 million, with the most recent change of -$52.87 million (-38.02%) on December 31, 2024.
- During the last 3 years, CLDX annual EBITDA has fallen by -$125.82 million (-190.41%).
- CLDX annual EBITDA is now -4213.63% below its all-time high of $4.67 million, reached on December 31, 2010.
Performance
CLDX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$62.98M-$1.11M(-1.80%)Summary
- As of today, CLDX quarterly EBITDA is -$62.98 million, with the most recent change of -$1.11 million (-1.80%) on June 30, 2025.
- Over the past year, CLDX quarterly EBITDA has dropped by -$17.46 million (-38.37%).
- CLDX quarterly EBITDA is now -329.55% below its all-time high of $27.44 million, reached on December 31, 2010.
Performance
CLDX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$231.40M-$17.46M(-8.16%)Summary
- As of today, CLDX TTM EBITDA is -$231.40 million, with the most recent change of -$17.46 million (-8.16%) on June 30, 2025.
- Over the past year, CLDX TTM EBITDA has dropped by -$71.21 million (-44.45%).
- CLDX TTM EBITDA is now -5061.49% below its all-time high of $4.66 million, reached on December 31, 2010.
Performance
CLDX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
CLDX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -38.0% | -38.4% | -44.5% |
| 3Y3 Years | -190.4% | -133.4% | -162.2% |
| 5Y5 Years | -286.4% | -431.6% | -385.5% |
CLDX EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -190.4% | at low | -133.1% | at low | -139.1% | at low |
| 5Y | 5-Year | -320.4% | at low | -562.4% | at low | -407.0% | at low |
| All-Time | All-Time | -4213.6% | at low | -329.6% | at low | -5061.5% | at low |
CLDX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$62.98M(-1.8%) | -$231.40M(-8.2%) |
| Mar 2025 | - | -$61.87M(-12.1%) | -$213.94M(-11.5%) |
| Dec 2024 | -$191.90M(-38.0%) | -$55.21M(-7.5%) | -$191.90M(-12.2%) |
| Sep 2024 | - | -$51.34M(-12.8%) | -$171.06M(-6.8%) |
| Jun 2024 | - | -$45.52M(-14.3%) | -$160.19M(-8.9%) |
| Mar 2024 | - | -$39.83M(-15.9%) | -$147.12M(-5.8%) |
| Dec 2023 | -$139.03M(-33.4%) | -$34.37M(+15.1%) | -$139.03M(-5.4%) |
| Sep 2023 | - | -$40.47M(-24.7%) | -$131.88M(-11.4%) |
| Jun 2023 | - | -$32.45M(-2.2%) | -$118.43M(-4.8%) |
| Mar 2023 | - | -$31.75M(-16.7%) | -$112.96M(-8.4%) |
| Dec 2022 | -$104.20M(-57.7%) | -$27.21M(-0.7%) | -$104.20M(-7.6%) |
| Sep 2022 | - | -$27.02M(-0.2%) | -$96.80M(-9.7%) |
| Jun 2022 | - | -$26.98M(-17.4%) | -$88.24M(-19.8%) |
| Mar 2022 | - | -$22.98M(-16.0%) | -$73.68M(-11.5%) |
| Dec 2021 | -$66.08M(-44.8%) | -$19.81M(-7.2%) | -$66.08M(-18.5%) |
| Sep 2021 | - | -$18.47M(-48.8%) | -$55.78M(-11.3%) |
| Jun 2021 | - | -$12.42M(+19.3%) | -$50.13M(-1.1%) |
| Mar 2021 | - | -$15.38M(-61.8%) | -$49.56M(-8.6%) |
| Dec 2020 | -$45.64M(+8.1%) | -$9.51M(+25.8%) | -$45.64M(+4.2%) |
| Sep 2020 | - | -$12.82M(-8.2%) | -$47.66M(-0.1%) |
| Jun 2020 | - | -$11.85M(-3.3%) | -$47.59M(+0.6%) |
| Mar 2020 | - | -$11.47M(+0.5%) | -$47.87M(+3.6%) |
| Dec 2019 | -$49.67M(+31.6%) | -$11.53M(+9.6%) | -$49.67M(+3.0%) |
| Sep 2019 | - | -$12.75M(-5.2%) | -$51.20M(+2.1%) |
| Jun 2019 | - | -$12.12M(+8.7%) | -$52.31M(+17.6%) |
| Mar 2019 | - | -$13.27M(-1.6%) | -$63.50M(+12.5%) |
| Dec 2018 | -$72.60M(+30.2%) | -$13.05M(+5.8%) | -$72.60M(+14.0%) |
| Sep 2018 | - | -$13.86M(+40.5%) | -$84.43M(+9.1%) |
| Jun 2018 | - | -$23.31M(-4.2%) | -$92.88M(+3.5%) |
| Mar 2018 | - | -$22.37M(+10.1%) | -$96.27M(+7.5%) |
| Dec 2017 | -$104.02M(+19.3%) | -$24.88M(-11.5%) | -$104.02M(+7.8%) |
| Sep 2017 | - | -$22.31M(+16.4%) | -$112.79M(+5.6%) |
| Jun 2017 | - | -$26.70M(+11.4%) | -$119.52M(+3.8%) |
| Mar 2017 | - | -$30.12M(+10.5%) | -$124.24M(+3.6%) |
| Dec 2016 | -$128.82M(-2.6%) | -$33.66M(-15.9%) | -$128.82M(-1.0%) |
| Sep 2016 | - | -$29.04M(+7.6%) | -$127.51M(+1.8%) |
| Jun 2016 | - | -$31.42M(+9.5%) | -$129.82M(+0.3%) |
| Mar 2016 | - | -$34.71M(-7.3%) | -$130.18M(-3.7%) |
| Dec 2015 | -$125.53M(-5.5%) | -$32.34M(-3.1%) | -$125.53M(-0.9%) |
| Sep 2015 | - | -$31.35M(+1.4%) | -$124.36M(-1.5%) |
| Jun 2015 | - | -$31.78M(-5.7%) | -$122.50M(-3.4%) |
| Mar 2015 | - | -$30.06M(+3.6%) | -$118.43M(+0.5%) |
| Dec 2014 | -$119.03M(-53.2%) | -$31.17M(-5.7%) | -$119.03M(-9.1%) |
| Sep 2014 | - | -$29.49M(-6.4%) | -$109.07M(-7.0%) |
| Jun 2014 | - | -$27.71M(+9.6%) | -$101.98M(-10.8%) |
| Mar 2014 | - | -$30.66M(-44.5%) | -$92.03M(-18.5%) |
| Dec 2013 | -$77.68M(-42.8%) | -$21.21M(+5.3%) | -$77.68M(-7.6%) |
| Sep 2013 | - | -$22.39M(-26.0%) | -$72.19M(-13.4%) |
| Jun 2013 | - | -$17.77M(-9.0%) | -$63.69M(-8.9%) |
| Mar 2013 | - | -$16.30M(-3.6%) | -$58.46M(-7.4%) |
| Dec 2012 | -$54.41M(-40.1%) | -$15.73M(-13.3%) | -$54.41M(-8.5%) |
| Sep 2012 | - | -$13.89M(-10.8%) | -$50.13M(-8.2%) |
| Jun 2012 | - | -$12.54M(-2.4%) | -$46.35M(-8.7%) |
| Mar 2012 | - | -$12.25M(-7.0%) | -$42.64M(-9.3%) |
| Dec 2011 | -$38.84M(-932.6%) | -$11.45M(-13.2%) | -$39.01M(>-9900.0%) |
| Sep 2011 | - | -$10.11M(-14.5%) | -$117.00K(-105.5%) |
| Jun 2011 | - | -$8.83M(-2.5%) | $2.13M(-29.8%) |
| Mar 2011 | - | -$8.61M(-131.4%) | $3.03M(-35.0%) |
| Dec 2010 | $4.67M(+114.1%) | $27.44M(+448.8%) | $4.66M(+113.6%) |
| Sep 2010 | - | -$7.87M(+0.8%) | -$34.42M(-4.3%) |
| Jun 2010 | - | -$7.93M(-13.6%) | -$32.99M(+0.1%) |
| Mar 2010 | - | -$6.98M(+40.1%) | -$33.04M(+0.1%) |
| Dec 2009 | -$33.07M(+26.2%) | -$11.65M(-80.8%) | -$33.07M(+21.1%) |
| Sep 2009 | - | -$6.44M(+19.2%) | -$41.90M(+3.1%) |
| Jun 2009 | - | -$7.98M(-13.9%) | -$43.22M(+3.5%) |
| Mar 2009 | - | -$7.00M(+65.8%) | -$44.79M(+0.0%) |
| Dec 2008 | -$44.81M(-205.2%) | -$20.48M(-163.7%) | -$44.81M(-57.6%) |
| Sep 2008 | - | -$7.76M(+18.7%) | -$28.42M(-14.6%) |
| Jun 2008 | - | -$9.55M(-36.0%) | -$24.81M(-45.3%) |
| Mar 2008 | - | -$7.02M(-71.5%) | -$17.07M(-21.5%) |
| Dec 2007 | -$14.68M(+18.0%) | -$4.09M(+1.3%) | -$14.05M(-0.2%) |
| Sep 2007 | - | -$4.15M(-128.8%) | -$14.02M(+9.4%) |
| Jun 2007 | - | -$1.81M(+54.6%) | -$15.47M(+20.6%) |
| Mar 2007 | - | -$3.99M(+1.8%) | -$19.50M(-8.9%) |
| Dec 2006 | -$17.91M(-7.0%) | -$4.07M(+27.4%) | -$17.91M(-2.4%) |
| Sep 2006 | - | -$5.60M(+4.0%) | -$17.50M(-9.5%) |
| Jun 2006 | - | -$5.83M(-142.4%) | -$15.98M(-10.5%) |
| Mar 2006 | - | -$2.41M(+34.1%) | -$14.46M(+13.6%) |
| Dec 2005 | -$16.74M | -$3.65M(+10.6%) | -$16.74M(-1.9%) |
| Sep 2005 | - | -$4.09M(+5.3%) | -$16.43M(-4.4%) |
| Jun 2005 | - | -$4.32M(+7.7%) | -$15.74M(-4.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2005 | - | -$4.68M(-39.9%) | -$15.00M(-26.4%) |
| Dec 2004 | -$11.87M(-16.3%) | -$3.34M(+1.7%) | -$11.87M(-6.3%) |
| Sep 2004 | - | -$3.40M(+5.0%) | -$11.16M(-17.8%) |
| Jun 2004 | - | -$3.58M(-132.1%) | -$9.48M(-9.7%) |
| Mar 2004 | - | -$1.54M(+41.6%) | -$8.64M(+14.9%) |
| Dec 2003 | -$10.21M(+20.3%) | -$2.64M(-53.6%) | -$10.15M(+5.2%) |
| Sep 2003 | - | -$1.72M(+37.3%) | -$10.70M(-19.1%) |
| Jun 2003 | - | -$2.74M(+10.1%) | -$8.99M(+19.6%) |
| Mar 2003 | - | -$3.05M(+4.6%) | -$11.17M(+12.8%) |
| Dec 2002 | -$12.81M(+42.6%) | -$3.20M(>-9900.0%) | -$12.81M(+20.6%) |
| Sep 2002 | - | -$600.00(+100.0%) | -$16.14M(+27.2%) |
| Jun 2002 | - | -$4.93M(-5.1%) | -$22.18M(+2.9%) |
| Mar 2002 | - | -$4.69M(+28.2%) | -$22.84M(-4.1%) |
| Dec 2001 | -$22.30M(-57.8%) | -$6.53M(-8.1%) | -$21.95M(-8.4%) |
| Sep 2001 | - | -$6.04M(-8.1%) | -$20.26M(-11.0%) |
| Jun 2001 | - | -$5.59M(-47.1%) | -$18.25M(-18.9%) |
| Mar 2001 | - | -$3.80M(+21.4%) | -$15.35M(-8.6%) |
| Dec 2000 | -$14.13M(-41.9%) | -$4.83M(-20.0%) | -$14.13M(-9.1%) |
| Sep 2000 | - | -$4.03M(-49.8%) | -$12.95M(-17.5%) |
| Jun 2000 | - | -$2.69M(-4.2%) | -$11.03M(-7.2%) |
| Mar 2000 | - | -$2.58M(+29.4%) | -$10.29M(-1.8%) |
| Dec 1999 | -$9.96M(-43.3%) | -$3.66M(-74.1%) | -$10.11M(-20.3%) |
| Sep 1999 | - | -$2.10M(-7.6%) | -$8.40M(0.0%) |
| Jun 1999 | - | -$1.95M(+18.7%) | -$8.40M(-5.7%) |
| Mar 1999 | - | -$2.40M(-23.1%) | -$7.95M(-14.4%) |
| Dec 1998 | -$6.95M(+4.9%) | -$1.95M(+7.2%) | -$6.95M(-5.2%) |
| Sep 1998 | - | -$2.10M(-40.0%) | -$6.61M(-1.5%) |
| Jun 1998 | - | -$1.50M(-7.1%) | -$6.51M(+4.4%) |
| Mar 1998 | - | -$1.40M(+12.9%) | -$6.81M(+6.8%) |
| Dec 1997 | -$7.31M(+35.3%) | -$1.61M(+19.6%) | -$7.31M(+12.0%) |
| Sep 1997 | - | -$2.00M(-11.1%) | -$8.30M(+1.2%) |
| Jun 1997 | - | -$1.80M(+5.3%) | -$8.40M(+22.9%) |
| Mar 1997 | - | -$1.90M(+26.9%) | -$10.90M(+1.8%) |
| Dec 1996 | -$11.30M(-1.8%) | -$2.60M(-23.8%) | -$11.10M(+2.6%) |
| Sep 1996 | - | -$2.10M(+51.2%) | -$11.40M(+8.8%) |
| Jun 1996 | - | -$4.30M(-104.8%) | -$12.50M(-16.8%) |
| Mar 1996 | - | -$2.10M(+27.6%) | -$10.70M(+3.6%) |
| Dec 1995 | -$11.10M(-27.6%) | -$2.90M(+9.4%) | -$11.10M(-8.8%) |
| Sep 1995 | - | -$3.20M(-28.0%) | -$10.20M(-9.7%) |
| Jun 1995 | - | -$2.50M(0.0%) | -$9.30M(-1.1%) |
| Mar 1995 | - | -$2.50M(-25.0%) | -$9.20M(-4.5%) |
| Dec 1994 | -$8.70M(-2.4%) | -$2.00M(+13.0%) | -$8.80M(+1.1%) |
| Sep 1994 | - | -$2.30M(+4.2%) | -$8.90M(+1.1%) |
| Jun 1994 | - | -$2.40M(-14.3%) | -$9.00M(-7.1%) |
| Mar 1994 | - | -$2.10M(0.0%) | -$8.40M(-1.2%) |
| Dec 1993 | -$8.50M(-107.3%) | -$2.10M(+12.5%) | -$8.30M(-33.9%) |
| Sep 1993 | - | -$2.40M(-33.3%) | -$6.20M(-26.5%) |
| Jun 1993 | - | -$1.80M(+10.0%) | -$4.90M(-8.9%) |
| Mar 1993 | - | -$2.00M(-81.8%) | -$4.50M(+8.2%) |
| Dec 1992 | -$4.10M(+30.5%) | - | - |
| Oct 1992 | - | -$1.10M(+21.4%) | -$4.90M(+14.0%) |
| Jul 1992 | - | -$1.40M(+17.6%) | -$5.70M(+3.4%) |
| Apr 1992 | - | -$1.70M(-142.9%) | -$5.90M(-11.3%) |
| Apr 1992 | -$5.90M(-55.3%) | - | - |
| Jan 1992 | - | -$700.00K(+63.2%) | -$5.30M(+3.6%) |
| Oct 1991 | - | -$1.90M(-18.8%) | -$5.50M(-25.0%) |
| Jul 1991 | - | -$1.60M(-45.5%) | -$4.40M(-12.8%) |
| Apr 1991 | -$3.80M(-171.4%) | -$1.10M(-22.2%) | -$3.90M(-50.0%) |
| Jan 1991 | - | -$900.00K(-12.5%) | -$2.60M(-44.4%) |
| Oct 1990 | - | -$800.00K(+27.3%) | -$1.80M(-228.6%) |
| Jul 1990 | - | -$1.10M(-650.0%) | $1.40M(-69.6%) |
| Apr 1990 | -$1.40M(-7.7%) | $200.00K(+300.0%) | $4.60M(+270.4%) |
| Jan 1990 | - | -$100.00K(-104.2%) | -$2.70M(-285.7%) |
| Oct 1989 | - | $2.40M(+14.3%) | -$700.00K(+41.7%) |
| Jul 1989 | - | $2.10M(+129.6%) | -$1.20M(+25.0%) |
| Apr 1989 | -$1.30M(+27.8%) | -$7.10M(-473.7%) | -$1.60M(-433.3%) |
| Jan 1989 | - | $1.90M(0.0%) | -$300.00K(+57.1%) |
| Oct 1988 | - | $1.90M(+11.8%) | -$700.00K(+50.0%) |
| Jul 1988 | - | $1.70M(+129.3%) | -$1.40M(+33.3%) |
| Apr 1988 | -$1.80M(-28.6%) | -$5.80M(-486.7%) | -$2.10M(-2200.0%) |
| Jan 1988 | - | $1.50M(+25.0%) | $100.00K(+116.7%) |
| Oct 1987 | - | $1.20M(+20.0%) | -$600.00K(+50.0%) |
| Jul 1987 | - | $1.00M(+127.8%) | -$1.20M(+40.0%) |
| Apr 1987 | -$1.40M(+22.2%) | -$3.60M(-550.0%) | -$2.00M(-400.0%) |
| Jan 1987 | - | $800.00K(+33.3%) | -$400.00K(+63.6%) |
| Oct 1986 | - | $600.00K(+200.0%) | -$1.10M(+31.3%) |
| Jul 1986 | - | $200.00K(+110.0%) | -$1.60M(+5.9%) |
| Apr 1986 | -$1.80M | -$2.00M(-2100.0%) | -$1.70M(-666.7%) |
| Jan 1986 | - | $100.00K(0.0%) | $300.00K(+50.0%) |
| Oct 1985 | - | $100.00K(0.0%) | $200.00K(+100.0%) |
| Jul 1985 | - | $100.00K | $100.00K |
FAQ
- What is Celldex Therapeutics, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Celldex Therapeutics, Inc.?
- What is Celldex Therapeutics, Inc. annual EBITDA year-on-year change?
- What is Celldex Therapeutics, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Celldex Therapeutics, Inc.?
- What is Celldex Therapeutics, Inc. quarterly EBITDA year-on-year change?
- What is Celldex Therapeutics, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Celldex Therapeutics, Inc.?
- What is Celldex Therapeutics, Inc. TTM EBITDA year-on-year change?
What is Celldex Therapeutics, Inc. annual EBITDA?
The current annual EBITDA of CLDX is -$191.90M
What is the all-time high annual EBITDA for Celldex Therapeutics, Inc.?
Celldex Therapeutics, Inc. all-time high annual EBITDA is $4.67M
What is Celldex Therapeutics, Inc. annual EBITDA year-on-year change?
Over the past year, CLDX annual EBITDA has changed by -$52.87M (-38.02%)
What is Celldex Therapeutics, Inc. quarterly EBITDA?
The current quarterly EBITDA of CLDX is -$62.98M
What is the all-time high quarterly EBITDA for Celldex Therapeutics, Inc.?
Celldex Therapeutics, Inc. all-time high quarterly EBITDA is $27.44M
What is Celldex Therapeutics, Inc. quarterly EBITDA year-on-year change?
Over the past year, CLDX quarterly EBITDA has changed by -$17.46M (-38.37%)
What is Celldex Therapeutics, Inc. TTM EBITDA?
The current TTM EBITDA of CLDX is -$231.40M
What is the all-time high TTM EBITDA for Celldex Therapeutics, Inc.?
Celldex Therapeutics, Inc. all-time high TTM EBITDA is $4.66M
What is Celldex Therapeutics, Inc. TTM EBITDA year-on-year change?
Over the past year, CLDX TTM EBITDA has changed by -$71.21M (-44.45%)